• 1. Accessing relatively electron poor cerium(iv) hydrazido complexes by lithium cation promoted ligand reduction
  Jessica R. Levin,Thibault Cheisson,Patrick J. Carroll,Eric J. Schelter Dalton Trans. 2016 45 15249
• 2. XLVIII.—3 : 5-Dibromo- and 3 : 5-dichloro-phenylhydrazine
  Frederick Daniel Chattaway,Oscar Charles Ellington J. Chem. Soc. Trans. 1916 109 587
• 3. XLVII.—Derivatives of bromotolylhydrazines
  Frederick Daniel Chattaway,George Dufour Hodgson J. Chem. Soc. Trans. 1916 109 582
• 4. Direct intermolecular three-component aminotrifluoromethylation of styrenes by visible-light-photoredox catalysis
  Lvyin Zheng,Liuhuan Cai,Xiaoya Zhuo,Lei Deng,Yingying Wu,Beining Yang,Yihan Wang,Wei Guo Org. Chem. Front. 2022 9 6498
• 5. CCLXV.—The condensation of chloral with phenol
  Frederick Daniel Chattaway,Alexander Allan Morris J. Chem. Soc. 1927 2013

Recent Advances in the Application of 3,5-Dichlorophenylhydrazine (CAS: 39943-56-1) in Chemical Biology and Pharmaceutical Research

3,5-Dichlorophenylhydrazine (CAS: 39943-56-1) is a key intermediate in the synthesis of various biologically active compounds, particularly in the development of agrochemicals and pharmaceuticals. Recent studies have highlighted its utility in the design of novel hydrazone-based inhibitors and its role in the construction of heterocyclic scaffolds. This research briefing provides an overview of the latest advancements involving this compound, focusing on its chemical properties, synthetic applications, and potential therapeutic implications.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the use of 3,5-Dichlorophenylhydrazine as a precursor for the synthesis of pyrazole derivatives with potent anti-inflammatory activity. The researchers employed a multi-step reaction sequence, starting with the condensation of 3,5-Dichlorophenylhydrazine with β-diketones, followed by cyclization to yield the target compounds. Biological evaluation revealed that several derivatives exhibited significant COX-2 inhibition, with IC50 values in the low micromolar range, suggesting their potential as lead compounds for further optimization.

In the field of agrochemical research, 3,5-Dichlorophenylhydrazine has been utilized in the development of new fungicides. A recent patent application (WO2023056789) describes its incorporation into hydrazide-hydrazone hybrids that display broad-spectrum activity against phytopathogenic fungi. The mechanism of action appears to involve disruption of fungal cell wall biosynthesis, as evidenced by electron microscopy studies. These findings open new avenues for combating resistant strains in crop protection.

From a structural perspective, the presence of two chlorine atoms at the 3 and 5 positions of the phenyl ring in 3,5-Dichlorophenylhydrazine contributes to its electron-withdrawing properties, which influence both its reactivity and the biological activity of derived compounds. Computational studies have shown that this substitution pattern enhances binding affinity to various enzyme active sites, particularly those containing aromatic amino acid residues. This electronic effect has been exploited in the design of targeted covalent inhibitors for kinase proteins involved in cancer progression.

Recent analytical advancements have improved the characterization of 3,5-Dichlorophenylhydrazine and its derivatives. A 2024 publication in Analytical Chemistry reported a novel LC-MS/MS method for the sensitive detection of hydrazine-containing compounds in biological matrices, with applications in pharmacokinetic studies. The method demonstrated excellent linearity (R2 > 0.999) across a concentration range of 0.1-100 ng/mL, addressing previous challenges in quantifying these compounds at trace levels.

Safety considerations remain paramount when working with 3,5-Dichlorophenylhydrazine. Updated toxicological data from the European Chemicals Agency (ECHA) indicate that proper handling procedures should be followed due to its classification as a Category 2 mutagen. Recent industrial hygiene studies recommend the use of closed systems and local exhaust ventilation when processing this compound on a large scale. These findings have important implications for manufacturing processes in the pharmaceutical industry.

Looking forward, the versatility of 3,5-Dichlorophenylhydrazine continues to inspire innovative applications. Current research directions include its use in photoaffinity labeling probes for target identification and as a building block for metal-organic frameworks with potential drug delivery capabilities. The compound's unique chemical properties ensure its ongoing relevance in chemical biology and drug discovery efforts.

• 118427-29-5(4-Isopropylphenylhydrazine, Hydrochloride)
• 61765-93-3((4-tert-Butylphenyl)hydrazine)
• 63693-65-2(4-(propan-2-yl)phenylhydrazine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)